BioAge develops a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging by using its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking individuals over the lifespan, to map out the key molecular pathways that impact healthy human aging.

Register for Details

For more details on financing and valuation for BioAge, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about BioAge

Forge green plus iconForge green minus icon

Is BioAge a publicly traded company?

BioAge is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Will BioAge go IPO?

BioAge has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

Forge green plus iconForge green minus icon

What is BioAge's IPO price?

The IPO price for BioAge will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in BioAge pre-IPO?

BioAge is privately held company and is not publicly traded, therefor investing in BioAge pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my BioAge shares?

To determine the value of your BioAge shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your BioAge shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell BioAge before it goes public?

Yes, you can seek to sell shares in BioAge while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is BioAge's funding to date?

BioAge has raised $321.26MM to date.
Forge green plus iconForge green minus icon

When was BioAge founded?

BioAge was founded in 2015.

Who are BioAge's major investors?

Redpoint Ventures
Andreessen Horowitz
Khosla Ventures
Ra Capital Management
AME Cloud Ventures
Longitude Capital
Caffeinated Capital
Bossanova Investimentos
Felicis
Cormorant Asset Management
Pear VC
Green Sands Equity
Sofinnova Investments
RTW Investments
Sands Capital
Osage University Partners
OrbiMed
Summit Peak Investments
CSC UpShot Ventures
Pivotal bioVenture Partners
Summer VC
Amgen
AARP Foundation
Springboard Enterprises

BioAge funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
2/13/2024

Series D and D-1

$194.39MM raised $XXX.XX $XXX.XX
12/3/2020

Series C

$90MM raised $XXX.XX $XXX.XX
1/24/2019

Series B

$22.93MM raised $XXX.XX $XXX.XX
7/28/2017

Series A-1, A-2, A-3 and A-4

$13.93MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.